Arkolith/Insider Trading/VKTX/Form 4

Lian Brian

President & CEO, DirectorViking Therapeutics, Inc. (VKTX) · full profile →Form 4 · filed Jan 6, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$8.3M
Net Open-Market Flow
-$8.3M
Transactions
5
4 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 6, 2025Sell(S)19K$43.32$823K2.4M
Jan 6, 2025Sell(S)175K$42.68$7.5M2.4M
Jan 3, 2025Grant(A)93K—$02.4M
Jan 3, 2025Grant(A)163K—$02.6M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 3, 2025Grant(A)78K—$078K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-002487) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML